Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma
- 1 March 2004
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 14 (2) , 354-359
- https://doi.org/10.1111/j.1048-891x.2004.014221.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Implication of Malignancy and Prognosis of p27kip1, Cyclin E, and Cdk2 Expression in Epithelial Ovarian TumorsGynecologic Oncology, 2001
- Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- p27 and Cyclin D1 Abnormalities in Uterine Papillary Serous CarcinomaGynecologic Oncology, 2000
- Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical CarcinomasGynecologic Oncology, 1999
- Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian TumorsThe American Journal of Pathology, 1999
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Principles of CDK regulationNature, 1995
- Mitosis in transitionCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Clinicopathological characteristics of p53 overexpression in endometrial cancersInternational Journal of Cancer, 1994